Animal Health Research & Development
Our global R&D team delivers advanced, preventive animal healthcare that helps veterinarians, pet and livestock owners and public health officials around the world improve animal health today and in the future. We work collaboratively with our internal colleagues in human health and with many external partners to leverage new technologies and science and develop targeted, comprehensive, long-term solutions for animal health. Our broad portfolio of veterinary vaccines, parasiticides and pharmaceuticals reflects Boehringer Ingelheim’s strong commitment to research and development.
R&D works across geographies and species to deliver a robust pipeline of safe and effective vaccines for companion animals and livestock. We bring together broad expertise in vaccinology, molecular biology, bioprocess, assay and clinical development. With customer insights and strong connections with academic institutes and startups, we leverage technology and experience to deliver value through innovation that improves the health and welfare of animals.
We are committed to not only updating vaccine strains as veterinary diseases evolve and spread due to globalization and climate change, but also finding solutions for new and emerging diseases. We are continually integrating new biotechnologies to enhance the quality of our vaccines.